Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Mesenchymal stromal cells (MSCs) are inherently tumor homing and can be isolated, expanded, and transduced, making them viable candidates for cell therapy. This tumor tropism has been used to deliver anticancer therapies to various tumor models. In this study, we sought to discover which molecules are the key effectors of human MSC tumor homing in vitro and using an in vivo murine model. In this study, we discover a novel role for macrophage migration inhibitory factor (MIF) as the key director of MSC migration and infiltration toward tumor cells. We have shown this major role for MIF using in vitro migration and invasion assays, in presence of different receptor inhibitors and achieving a drastic decrease in both processes using MIF inhibitor. Additionally, we demonstrate physical interaction between MIF and three receptors: CXCR2, CXCR4, and CD74. CXCR4 is the dominant receptor used by MIF in the homing tumor context, although some signaling is observed through CXCR2. We demonstrate downstream activation of the MAPK pathway necessary for tumor homing. Importantly, we show that knockdown of either CXCR4 or MIF abrogates MSC homing to tumors in an in vivo pulmonary metastasis model, confirming the in vitro two-dimensional and three-dimensional assays. This improved understanding of MSC tumor tropism will further enable development of novel cellular therapies for cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
Tarnowski, M., Grymula, K., Liu, R., Tarnowska, J., Drukala, J., Ratajczak, J., Mitchell, R. A., Ratajczak, M. Z., & Kucia, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0288 · Cited by 136
Research works printed but not linked: 50
- Chen, 2008, Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke, J. Anat., 213, 249, 10.1111/j.1469-7580.2008.00948.x · DOI
- Askari, 2003, Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy, Lancet, 362, 697, 10.1016/S0140-6736(03)14232-8 · DOI · Paper page
- Zanjani, 1999, Homing of human cells in the fetal sheep model: modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function, Blood, 94, 2515, 10.1182/blood.V94.7.2515.419k15_2515_2522 · doi:10.1182/blood.v94.7.2515.419k15_2515_2522
- Gao, 2009, Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium, Stem Cells, 27, 857, 10.1002/stem.23 · DOI · Paper page
- Komarova, 2010, Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor, J. Ovarian Res., 3, 12, 10.1186/1757-2215-3-12 · DOI
- Ara, 2003, Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny, Immunity, 19, 257, 10.1016/S1074-7613(03)00201-2 · DOI · Paper page
- Geminder, 2001, A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma, J. Immunol., 167, 4747, 10.4049/jimmunol.167.8.4747 · DOI · Paper page
- Sun, 2003, Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo, J. Cell. Biochem., 89, 462, 10.1002/jcb.10522 · DOI · Paper page
- Porcile, 2004, CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line, Ann. N. Y. Acad. Sci., 1030, 162, 10.1196/annals.1329.021 · DOI
- Phillips, 2003, The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases, Am. J. Respir. Crit. Care Med., 167, 1676, 10.1164/rccm.200301-071OC · DOI · Paper page
- Bando, 2002, Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread, Jpn. J. Cancer Res., 93, 389, 10.1111/j.1349-7006.2002.tb01269.x · DOI
- Kamimura, 2000, Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung, Cancer, 89, 334, 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N · doi:10.1002/1097-0142(20000715)89:2<334::aid-cncr18>3.0.co;2-n
- Markert, 2001, Differential gene expression profiling in human brain tumors, Physiol. Genomics, 5, 21, 10.1152/physiolgenomics.2001.5.1.21 · DOI · Paper page
- Meyer-Siegler, 1998, Expression of macrophage migration inhibitory factor in the human prostate, Diagn. Mol. Pathol., 7, 44, 10.1097/00019606-199802000-00008 · doi:10.1097/00019606-199802000-00008
- Shimizu, 1999, High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis, Biochem. Biophys. Res. Commun., 264, 751, 10.1006/bbrc.1999.1584 · DOI · Paper page
- Takahashi, 1998, Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth, Mol. Med., 4, 707, 10.1007/BF03401765 · DOI · Paper page
- Winner, 2007, Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation, Methods Enzymol., 435, 355, 10.1016/S0076-6879(07)35018-0 · DOI
- Han, 2008, Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma, Clin. Orthop. Relat. Res., 466, 2107, 10.1007/s11999-008-0333-1 · doi:10.1007/s11999-008-0333-1
- Meyer-Siegler, 2002, Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma, Cancer, 94, 1449, 10.1002/cncr.10354 · DOI
- Tomiyasu, 2002, Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance, Clin. Cancer Res., 8, 3755
- Borghese, 2011, CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease, Expert Opin. Ther. Targets, 15, 237, 10.1517/14728222.2011.550879 · DOI · Paper page
- Stern, 2006, MHC class II compartment subtypes: structure and function, Curr. Opin. Immunol., 18, 64, 10.1016/j.coi.2005.11.005 · DOI
- Henne, 1995, Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens, Immunology, 84, 177
- Bernhagen, 2007, MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment, Nat. Med., 13, 587, 10.1038/nm1567 · DOI · Paper page
- Gordin, 2010, c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74, J. Immunol., 185, 2020, 10.4049/jimmunol.0902566 · DOI
- Cho, 2010, Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast, Proc. Natl. Acad. Sci. USA, 107, 11313, 10.1073/pnas.1002716107 · DOI · Paper page
- Vera, 2008, Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association, PLoS One, 3, e3898, 10.1371/journal.pone.0003898 · DOI
- Moser, 2001, Lymphocyte traffic control by chemokines, Nat. Immunol., 2, 123, 10.1038/84219 · DOI · Paper page
- Rot, 2004, Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells, Annu. Rev. Immunol., 22, 891, 10.1146/annurev.immunol.22.012703.104543 · DOI · Paper page
- Thelen, 2008, How chemokines invite leukocytes to dance, Nat. Immunol., 9, 953, 10.1038/ni.f.207 · DOI · Paper page
- Burger-Kentischer, 2002, Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis, Circulation, 105, 1561, 10.1161/01.CIR.0000012942.49244.82 · DOI · Paper page
- Schober, 2004, Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice, Circulation, 109, 380, 10.1161/01.CIR.0000109201.72441.09 · DOI · Paper page
- Zernecke, 2008, Chemokines in atherosclerosis: an update, Arterioscler. Thromb. Vasc. Biol., 28, 1897, 10.1161/ATVBAHA.107.161174 · DOI · Paper page
- Dessein, 2010, Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells, Cancer Res., 70, 4644, 10.1158/0008-5472.CAN-09-3828 · DOI
- Simons, 2011, Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment, J. Cell. Mol. Med., 15, 668, 10.1111/j.1582-4934.2010.01041.x · DOI
- Aguilar, 2007, Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung, Stem Cells, 25, 1586, 10.1634/stemcells.2006-0762 · DOI · Paper page
- Fischer-Valuck, 2010, Migratory response of mesenchymal stem cells to macrophage migration inhibitory factor and its antagonist as a function of colony-forming efficiency, Biotechnol. Lett., 32, 19, 10.1007/s10529-009-0110-6 · DOI
- Barrilleaux, 2010, Activation of CD74 inhibits migration of human mesenchymal stem cells, In Vitro Cell. Dev. Biol. Anim., 46, 566, 10.1007/s11626-010-9279-1 · DOI
- Barrilleaux, 2009, Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cells, Tissue Eng. Part A, 15, 2335, 10.1089/ten.tea.2008.0434 · DOI
- Rattigan, 2010, Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu, Exp. Cell Res., 316, 3417, 10.1016/j.yexcr.2010.07.002 · DOI · Paper page
- Kim, 2011, CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas, Biochem. Biophys. Res. Commun., 407, 741, 10.1016/j.bbrc.2011.03.093 · DOI
- Dwyer, 2007, Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells, Clin. Cancer Res., 13, 5020, 10.1158/1078-0432.CCR-07-0731 · DOI · Paper page
- Belema-Bedada, 2008, Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2, Cell Stem Cell, 2, 566, 10.1016/j.stem.2008.03.003 · DOI · Paper page
- Onodera, 2004, Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta, Arthritis Rheum., 50, 1437, 10.1002/art.20190 · DOI
- Kim, 2007, Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis, J. Rheumatol., 34, 927
- Binsky, 2007, IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival, Proc. Natl. Acad. Sci. USA, 104, 13408, 10.1073/pnas.0701553104 · DOI · Paper page
- Cheng, 2010, Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules, J. Immunol., 185, 1238, 10.4049/jimmunol.0904104 · DOI · Paper page
- Ehtesham, 2004, Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4, Neoplasia, 6, 287, 10.1593/neo.03427 · DOI · Paper page
- Barbero, 2003, Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt, Cancer Res., 63, 1969
- Baron, 2011, Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells, J. Neurosci. Res., 89, 711, 10.1002/jnr.22595 · DOI
Cited by
Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?
Becker, A. D., & Riet, I. V. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i3.73 · Cited by 460
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Hmadcha, A., Martin-Montalvo, A., Gauthier, B. R., Soria, B., & Capilla-Gonzalez, V. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00043 · Cited by 341
Zheng, Y., Wang, G., Chen, R., Hua, Y., & Cai, Z. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0780-x · Cited by 127
“A large amount of cytokines secreted by the TME and tumor cells are involved in this process, including interleukin (IL)-6, transforming growth factor (TGF)-β, stromal-derived factor (SDF)-1, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, macrophage inhibition factor (MIF), and IL-1α [8, 11] (Fig.”
BackgroundRecent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, G., & Lam, P. Y. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.004 · Cited by 117
“Migration of human BM-MSCs towards hepatoma cells involves the release of CCL15 and CCL20 by cancer cells [12] and the chemokine macrophage inhibitory factor secreted by various cancer types can attract human BM-MSCs in a CXCR4-dependent manner [13].”
BackgroundSlama, Y., Ah-Pine, F., Khettab, M., Arcambal, A., Begue, M., Dutheil, F., & Gasque, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713511 · Cited by 57
Metadata
- Authors
- Lourenco, S., Teixeira, V. H., Kalber, T., Jose, R. J., Floto, R. A., & Janes, S. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-01
- Volume
- 194
- Issue
- 7
- Pages
- 3463-3474
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2127755727
- Cited by
- 151
- References
- 3
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors. https://app.cochat.ai/papers/10.4049/jimmunol.1402097
- The paper
- Lourenco, S., Teixeira, V. H., Kalber, T., Jose, R. J., Floto, R. A., & Janes, S. M. (2015). Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1402097
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.